Jci_page_head_homepage_01 Jci_page_head_homepage_02
Laurence Panicot-Dubois, Grace M. Thomas, Barbara C. Furie, Bruce Furie, Dominique Lombardo, Christophe Dubois
Published in Volume 117, Issue 12
J Clin Invest. 2007; 117(12):3708–3719 doi:10.1172/JCI32655
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 9
Involvement of CXCR4 in thrombus formation.

Wild-type mice were infused with Alexa Fluor 647–conjugated anti-mouse CD41 Fab fragment (0.25 μg/g mouse), pAbantipeptide (0.6 μg/g mouse), and Alexa Fluor 488–conjugated goat anti-rabbit antibody (0.6 μg/g mouse) prior to injury. (A) Top row: Thrombus formation after laser injury in the absence of AMD3100. Bottom row: Thrombus formation after laser injury following infusion of AMD3100. Fluorescence signal of accumulated anti-CD41 antibody, red; fluorescence signal of accumulated pAbantipeptide, green; merge, yellow. Original magnification, ×600. (B) Median BSDL (pAbantipeptide) integrated fluorescence intensity in laser-induced thrombi in wild-type mice before and after treatment as in A with AMD3100 (1.25 μg/g mouse). For A and B, 30 thrombi in 3 wild-type mice were analyzed.